Find out all about your favorite commercial!

What is Intra-Cellular Therapies Caplyta?

Intra-Cellular Therapies Caplyta is an antipsychotic drug used in the treatment of schizophrenia in adults. It was approved by the U.S. Food and Drug Administration (FDA) in December 2019. The drug's active ingredient is lumateperone, and it works by modulating serotonin, dopamine, and glutamate neurotransmitter systems in the brain.

Caplyta is manufactured by Intra-Cellular Therapies, Inc., a biopharmaceutical company based in New York City that focuses on the development of innovative therapies for the treatment of neuropsychiatric and neurodegenerative disorders. The company is also known for its patient assistance program, which helps eligible patients access Caplyta who do not have insurance.

Since its approval, Caplyta has seen significant market growth. In 2020, the U.S. antipsychotic drug market was valued at over $12 billion, and Caplyta has the potential to become a blockbuster drug, with an estimated annual revenue of $700 million in the U.S. alone.

In addition to its efficacy in treating schizophrenia, Caplyta has also been found to be well-tolerated by patients, with fewer side effects compared to other antipsychotic drugs. The drug has also undergone several clinical trials, with positive results showing significant improvement in patients' symptoms.

In summary, Intra-Cellular Therapies Caplyta is a promising treatment for schizophrenia that has been approved by the FDA and has seen significant market growth. The drug's manufacturer, Intra-Cellular Therapies, Inc., is dedicated to the development of innovative therapies for neuropsychiatric and neurodegenerative disorders and offers a patient assistance program for eligible patients.

Frequently Asked Questions about intra-cellular therapies caplyta

Caplyta belongs to the class of medicines known as atypical antipsychotics. Atypical means it is less likely than older antipsychotics to cause side effects, such as extrapyramidal symptoms (EPS).

Lumateperone is used to treat certain mental/mood disorders (such as schizophrenia, episodes of depression associated with bipolar disorder). This medication helps you to think more clearly, feel less nervous, and take part in everyday life.

CAPLYTA belongs to a class of drugs known as atypical antipsychotics.

Caplyta FDA Approval History Caplyta (lumateperone) is an atypical antipsychotic for the treatment of schizophrenia and bipolar depression. Caplyta is indicated for the treatment of: Schizophrenia in adults.

Caplyta has an average rating of 5.6 out of 10 from a total of 125 reviews on Drugs.com. 45% of reviewers reported a positive experience, while 41% reported a negative experience.

Caplyta has an average rating of 6.1 out of 10 from a total of 79 reviews for the treatment of Bipolar Disorder. 48% of reviewers reported a positive experience, while 33% reported a negative experience.

The trial's patients had a mean baseline MADRS of about 31, and Caplyta on average led to an additional 5.7-point reduction versus placebo. The average reduction in patients with bipolar depression and major depressive disorder was 5.7 points and 5.9 points, respectively.

CAPLYTA may cause serious side effects, including uncontrolled body movements (tardive dyskinesia, TD) in your face, tongue, or other body parts. TD may not go away, even if you stop taking CAPLYTA. It may also occur after you stop taking CAPLYTA.

TV spots

TV commercials Intra-Cellular Therapies Caplyta

CAPLYTA TV Spot, 'Real Progress'
CAPLYTA TV Spot, 'See Progress Differently'
Actors

Actors who starred in Intra-Cellular Therapies Caplyta commercials

Sabrina Sanchez photo
Advertisers

Advertisers of commercials featuring Intra-Cellular Therapies Caplyta

Intra-Cellular Therapies Caplyta commercials
CAPLYTA

What is CAPLYTA?CAPLYTA is a brand name for the drug lumateperone, which is an atypical antipsychotic medication indicated for the treatment of schizophrenia in adults. It is manufactured by Intra-Cel...

Goods

Other goods

Oofos OOriginal Sandal logo
Oofos OOahh Sport Flex Sandals logo
Oofos OOmg Sport Low logo
Oofos OOlala Sandal logo
Oofos OOmg Low logo
Oofos Oocandoo Sandal logo
Country Road TV The Very Best of Country's Family Reunion: Volume One logo
Ninja Cooking Coffee Bar System logo
Calvin Klein X-Fit Slim Fit Formal Tuxedo Separates logo
Universal Pictures Red Dawn logo
L.L. Bean Ridge Runner Storm Hunting Jacket logo
L.L. Bean Ridge Runner Storm Hunting Pants logo